Zaylaa, Amer https://orcid.org/0000-0001-7691-1327
Dax, Jürgen
Sippel, Katrin
Semeia, Lorenzo
Frohlich, Joel
Gallard, Alban
Wallois, Fabrice
Eswaran, Hari
Birkenfeld, Andreas L.
Preissl, Hubert
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-21-CE19-0046 fMEG-OPM)
Deutsche Forschungsgemeinschaft (PR 496/11-1)
German Federal Ministry of Education and Research (BMBF) to the German Centre for Diabetes Research (DZD01GI0925)
Hermann von Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V. IVF
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Article History
Received: 25 September 2025
Accepted: 2 January 2026
First Online: 5 February 2026
Declarations
:
: Joel Frohlich receives consulting fees from IAMA Therapeutics and funding from the Bial Foundation, both unrelated to this project. All remaining authors have no conflict of interest to declare.
: Datasets were used from 2 studies in our fetal MEG database in fMEG Zentrum-Tübingen. Ethical approval for both studies, with corresponding numbers 339/2010OB1 and 476/2008MPG1, was obtained from the local Ethics Committee of the Medical Faculty of the University of Tübingen. Participants provided written consent for their initial involvement and for the subsequent reuse of their data in further research.